Providing the missing data layer for better asthma care
aflo objectively measures how inhaled treatment is used in everyday life—capturing technique, timing and inhalation performance, not simply actuation.
Managing your airways condition
aflo combines a connected inhaler sensor, patient co-designed app and clinician portal.
The platform records defined parameters of metered-dose inhaler use. Patients receive immediate feedback to help them practise and maintain correct technique.
Recorded data provide an objective picture of how inhaled treatment is used outside the clinic.
Healthcare professionals can review this information alongside symptoms, lung function, inflammatory biomarkers and other clinical information. Clinical interpretation and treatment decisions remain with the healthcare professional.
Get in touch to learn about our clinical trials.
The scale of the problem
Guidelines require inhaler technique and adherence to be assessed before treatment escalation. But these factors are still commonly evaluated through patient recall, dispensing records and brief observation in the clinic and don’t show whether treatment was used consistently and administered effectively.
Critical inhaler errors are reported in up to 90% of patients and are associated with poorer asthma control, increased healthcare use and avoidable treatment escalation.*
aflo replaces this incomplete picture with objective, longitudinal inhaler-use data**.
*Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes Usmani et al. Respiratory Research (2018) 19:10 DOI 10.1186/s12931-017-0710-y.
**UK RCT NCT05733299
aflo doesn't make the treatment decision. It provides the objective evidence that was previously missing from it.
Objective inhaler-use data: aflo records how an inhaler is prepared and used, including actuation, coordination, inspiratory flow and inhaled volume. It makes aspects of treatment delivery visible that cannot be established from prescriptions or dose counts alone.
Evidence beyond the clinic: A technique assessment performed during one appointment provides only a snapshot. aflo captures inhaler-use parameters over time, giving patients feedback during everyday use and clinical teams an objective longitudinal record for review.
Better informed assessment: persistent poor control can have several causes. aflo provides clinical teams with evidence of inhaler use and technique that can be reviewed alongside symptoms, lung function, FeNO and other clinical information.
Where aflo makes the difference
.svg)
.svg)
.svg)
'I went for a run after work and didn't have to stop to use my blue inhaler. That's the first time for years.'
Clinical trial patient 2024
Improve your symptom control with aflo
aflo provides automated feedback to help patients improve and maintain their inhaler technique. It records inhaler-use and inhalation parameters over time, allowing patients to see their progress and authorised healthcare professionals to review the data through the clinician portal.
Clinical studies have shown improvements in inhaler proficiency and asthma-control measures in the populations evaluated. Individual results may vary, and aflo does not diagnose a condition, assess treatment effectiveness or recommend changes to prescribed therapy.
